Precipio, Inc. Common Stock

PRPO

Precipio, Inc. is a biotechnology company specializing in diagnostic and testing services for cancer and infectious diseases. It develops and offers cutting-edge laboratory techniques, including oncology diagnostics and pathogen testing, aimed at improving patient outcomes through innovative and high-quality testing solutions.

$24.84 +0.82 (3.43%)
🚫 Precipio, Inc. Common Stock does not pay dividends

Company News

Precipio to Showcase its BCR::ABL1 panel at 2025 ASH (American Society of Hematology) Meeting
GlobeNewswire Inc. • Precipio, Inc. • December 5, 2025

Precipio conducted a comprehensive study with Memorial Sloan Kettering Cancer Center, evaluating their BCR::ABL1 assay using 895 patient samples. The study demonstrated superior performance and positive impacts on patient care and laboratory workflows.

Crude Oil Moves Lower; Carvana Shares Surge
Benzinga • Lisa Levin • June 8, 2023

U.S. stocks traded higher toward the end of trading, with Dow Jones gaining more than 150 points on Thursday. The Dow traded up 0.53% to 33,844.18 while the NASDAQ rose 0.90% to 13,223.26. The S&P 500, also rose, gaining, 0.57% to 4,291.82. Check This Out: Top 5 Tech Stocks That You May Want To Dump In Q2   Leading and Lagging Sectors Consumer...

Best Penny Stocks to Buy Today? 3 For Your Watchlist Right Now
PennyStocks • D. Marie • November 19, 2021

Which penny stocks are you watching right now? The post Best Penny Stocks to Buy Today? 3 For Your Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Wall Street Breakfast: What Moved Markets
Seeking Alpha • Wall Street Breakfast • May 8, 2021

Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify.

Need to Know: Sweating over stock picks? Get rid of the losers and watch your portfolio fly, says this index manager
MarketWatch • MarketWatch • May 4, 2021

Investors could learn a thing or two from our call of the day, which is all about the stocks your portfolio is begging you to get rid of.

Related Companies